Dr. Filipink is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3705 5th Ave
2ND floor
Pittsburgh, PA 15213Phone+1 412-692-5520Fax+1 412-692-6787
Education & Training
- UPMC Medical EducationFellowship, Neurodevelopmental Disabilities, 2004 - 2008
- UPMC Medical EducationResidency, Pediatrics, 2002 - 2004
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2002
Certifications & Licensure
- PA State Medical License 2002 - 2024
- American Board of Pediatrics Pediatrics
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Neurodevelopmental Disabilities
Publications & Presentations
PubMed
- 13 citationsThe Effects of Sigma, PCP, and Opiate Receptor Ligands in Rats Trained With Ibogaine as a Discriminative StimulusScott Helsley, Robyn A. Filipink, Wayne D. Bowen, Richard A. Rabin, Jerrold C. Winter
Pharmacology, Biochemistry, and Behavior. 1998-02-01 - 404 citationsPhenotypic Heterogeneity of Genomic Disorders and Rare Copy-Number VariantsSanthosh Girirajan, Jill A. Rosenfeld, Bradley P. Coe, Sumit Parikh, Neil R. Friedman
The New England Journal of Medicine. 2012-10-03 - 28 citationsSerotonergic receptor subtypes and hallucinogen-induced stimulus control.Jerrold C. Winter, David Fiorella, D. M. Timineri, Robyn A. Filipink, Scott Helsley
Pharmacology, Biochemistry, and Behavior. 1999-10-01
Press Mentions
- A Baldwin Family Confronts an Exceptionally Rare Disease — TwiceMarch 19th, 2023
- What Is Fragile X Syndrome?July 12th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: